Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06490900 · ClinicalTrials.gov registry record · NA
Influence of Intermittent Hypoxia on Glycemic Control
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT06490900: Completed NA study, sponsored by University of Texas at Austin.
NCT06490900 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06490900, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The aim of this research project is to determine the effect of intermittent hypoxia on glucose uptake in response to an oral glucose tolerance test in healthy individuals, individuals with prediabetes and patients with type 2 diabetes.
Primary Outcome
Plasma glucose levels obtained from a venous catheter during a 2-hour oral glucose tolerance test
Interventions
- BEHAVIORAL Intermittent hypoxia
- BEHAVIORAL Intermittent normoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-02-05 |
| Est. Completion | 2024-11-26 |
| Phase | NA |
What the finished NCT06490900 record still lists
NCT06490900 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Intermittent hypoxia is the first listed.
NCT06490900 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06490900 about?
NCT06490900 is a clinical study titled "Influence of Intermittent Hypoxia on Glycemic Control". The aim of this research project is to determine the effect of intermittent hypoxia on glucose uptake in response to an oral glucose tolerance test in healthy individuals, individuals with prediabetes and patients with type 2 diabetes.
What is the current status of trial NCT06490900?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2021-02-05. Estimated completion is 2024-11-26.
What interventions are being tested in trial NCT06490900?
The interventions under investigation include: Intermittent hypoxia (BEHAVIORAL), Intermittent normoxia (BEHAVIORAL).
Who is sponsoring clinical trial NCT06490900?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06490900's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI